Bristol-Myers, Takeda Hit With False Marking Suits
Promote Innovation LLC has fired off false patent marking lawsuits against Bristol-Myers Squibb Co., Ranbaxy Laboratories Inc., Takeda Pharmaceuticals America Inc. and Eisai Inc., alleging that the drug companies label their...To view the full article, register now.
Already a subscriber? Click here to view full article